ConductScience.org, home

Paper34769259

Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents.

Carlsen L and 1 other. Int J Mol Sci, 2021. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents. Papers, record 34769259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34769259

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.24
iCite
Revised in PubMed
2021-12-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carlsen LLindseyhttps://orcid.org/0000-0003-0512-1760
2El-Deiry WSWafik Shttps://orcid.org/0000-0002-9577-8266

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
ApoptosisMajor topic
DNA DamageMajor topic
DNA, NeoplasmMajor topic
NeoplasmsMajor topic
Tumor Suppressor Protein p53Major topic
DNA Repair
Humans

Source PubMed

Download CSV of topics

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132303678The p53/MDM2/MDMX-targeted therapies-a clinical synopsis.Cell Death Dis2020https://conductscience.org/library/papers/32303678PubMed
214580351p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage.Mol Cell2003https://conductscience.org/library/papers/14580351PubMed
325806108New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy.J Immunother Cancer2015https://conductscience.org/library/papers/25806108PubMed
418779317p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines.Mol Cell Biol2008https://conductscience.org/library/papers/18779317PubMed
531365877Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.Cell Rep2019https://conductscience.org/library/papers/31365877PubMed
629099489Deconstructing networks of p53-mediated tumor suppression in vivo.Cell Death Differ2018https://conductscience.org/library/papers/29099489PubMed
726732534Targeting Oncogenic Mutant p53 for Cancer Therapy.Front Oncol2015https://conductscience.org/library/papers/26732534PubMed
833932560Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.Biochim Biophys Acta Rev Cancer2021https://conductscience.org/library/papers/33932560PubMed
917334395p63 and p73 in human cancer: defining the network.Oncogene2007https://conductscience.org/library/papers/17334395PubMed
1022673234The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells.Cancer Res2012https://conductscience.org/library/papers/22673234PubMed
1128280037Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity.Cancer Res2017https://conductscience.org/library/papers/28280037PubMed
1221764762Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.Cancer Res2011https://conductscience.org/library/papers/21764762PubMed
1310212189p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389.J Biol Chem1999https://conductscience.org/library/papers/10212189PubMed
1431282934p53 modifications: exquisite decorations of the powerful guardian.J Mol Cell Biol2019https://conductscience.org/library/papers/31282934PubMed
1521941086Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.Cell Cycle2011https://conductscience.org/library/papers/21941086PubMed
1630320184Immunogenic effects of chemotherapy-induced tumor cell death.Genes Dis2018https://conductscience.org/library/papers/30320184PubMed
1723965983p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1.Nat Commun2013https://conductscience.org/library/papers/23965983PubMed
1830450666Recent clinical trends in Toll-like receptor targeting therapeutics.Med Res Rev2019https://conductscience.org/library/papers/30450666PubMed
1917251932Restoration of p53 function leads to tumour regression in vivo.Nature2007https://conductscience.org/library/papers/17251932PubMed
2011875500Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.Nat Med2002https://conductscience.org/library/papers/11875500PubMed

See all 102 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42598159Association between the expression of GSTP1 and mutant p53, poor chemotherapy response and metastasis in patients with osteosarcoma.Oncol Lett2026https://conductscience.org/library/papers/42598159PubMed
41985006PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells.Blood Adv2026https://conductscience.org/library/papers/41985006PubMed
39060302Functional evaluation of germline TP53 variants identified in Brazilian families at-risk for Li-Fraumeni syndrome.Sci Rep2024https://conductscience.org/library/papers/39060302PubMed
38366290Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance.Mol Biol Rep2024https://conductscience.org/library/papers/38366290PubMed
38311377Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.Cancer Commun (Lond)2024https://conductscience.org/library/papers/38311377PubMed
38135693The dual activity of CaONPs as a cancer treatment substance and at the same time resistance to harmful microbes.Sci Rep2023https://conductscience.org/library/papers/38135693PubMed
38005258Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights.Molecules2023https://conductscience.org/library/papers/38005258PubMed
37509605The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo.Biomedicines2023https://conductscience.org/library/papers/37509605PubMed
37407287Transcriptional pausing induced by ionizing radiation enables the acquisition of radioresistance in nasopharyngeal carcinoma.J Mol Cell Biol2024https://conductscience.org/library/papers/37407287PubMed
37108395Resistance to TOP-1 Inhibitors: Good Old Drugs Still Can Surprise Us.Int J Mol Sci2023https://conductscience.org/library/papers/37108395PubMed
37047251Plumbagin Exhibits Genotoxicity and Induces G2/M Cell Cycle Arrest via ROS-Mediated Oxidative Stress and Activation of ATM-p53 Signaling Pathway in Hepatocellular Cells.Int J Mol Sci2023https://conductscience.org/library/papers/37047251PubMed
36910143ROS production in response to high-power microwave pulses induces p53 activation and DNA damage in brain cells: Radiosensitivity and biological dosimetry evaluation.Front Cell Dev Biol2023https://conductscience.org/library/papers/36910143PubMed
36775894Diepoxybutane induces the p53-dependent transactivation of the CCL4 gene that mediates apoptosis in exposed human lymphoblasts.J Biochem Mol Toxicol2023https://conductscience.org/library/papers/36775894PubMed
36214609MYC and therapy resistance in cancer: risks and opportunities.Mol Oncol2022https://conductscience.org/library/papers/36214609PubMed
36090037Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53.Front Mol Biosci2022https://conductscience.org/library/papers/36090037PubMed
35806255Targeted Modulation of Interferon Response-Related Genes with IFN-Alpha/Lambda Inhibition.Int J Mol Sci2022https://conductscience.org/library/papers/35806255PubMed
35792674The Elephant Evolved p53 Isoforms that Escape MDM2-Mediated Repression and Cancer.Mol Biol Evol2022https://conductscience.org/library/papers/35792674PubMed
35634298Cytosolic p53 Inhibits Parkin-Mediated Mitophagy and Promotes Acute Liver Injury Induced by Heat Stroke.Front Immunol2022https://conductscience.org/library/papers/35634298PubMed
35312310Nitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes.Chem Res Toxicol2022https://conductscience.org/library/papers/35312310PubMed
35208631Ofeleein i mi Vlaptin-Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic.Medicina (Kaunas)2022https://conductscience.org/library/papers/35208631PubMed

See all 21 cited byDownload CSV of cited by

Genes64

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABI210152PubTator's text mininghttps://conductscience.org/library/genes/10152NCBI Gene
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BTG27832PubTator's text mininghttps://conductscience.org/library/genes/7832NCBI Gene
CARM110498PubTator's text mininghttps://conductscience.org/library/genes/10498NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CDKN1A1026PubTator's text mininghttps://conductscience.org/library/genes/1026NCBI Gene
CREBBP1387PubTator's text mininghttps://conductscience.org/library/genes/1387NCBI Gene
CSE1L1434PubTator's text mininghttps://conductscience.org/library/genes/1434NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
CYCS54205PubTator's text mininghttps://conductscience.org/library/genes/54205NCBI Gene
DYRK28445PubTator's text mininghttps://conductscience.org/library/genes/8445NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
FOXO44303PubTator's text mininghttps://conductscience.org/library/genes/4303NCBI Gene
GADD45A1647PubTator's text mininghttps://conductscience.org/library/genes/1647NCBI Gene
GSK3B2932PubTator's text mininghttps://conductscience.org/library/genes/2932NCBI Gene
H3P12100689229PubTator's text mininghttps://conductscience.org/library/genes/100689229NCBI Gene

See all 64 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34769259

GET https://conductscience.org/api/papers/v1/34769259/references?page=2